Orange Book product · Generic (ANDA)
NADOLOL AND BENDROFLUMETHIAZIDE
BENDROFLUMETHIAZIDE; NADOLOL
Generic (ANDA)ANDA 077833DISCN IMPAX LABS
At a glance
Mar 30, 2007
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 30, 2007
19 yr 6 mo ago
Today
Pharmaceutical detail
Active ingredient
BENDROFLUMETHIAZIDE; NADOLOL
Strength
5MG;40MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
ANDA 077833
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of BENDROFLUMETHIAZIDE; NADOLOL
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
